Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
14
datasets available to search
ShareScore release 0.9.0
Dataset results
14 results for “HIV Positive Pregnant Women.”
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
ClinicalTrials.gov study NCT04124536. IPD Sharing: YES. Countries: 1. Publications: 1.
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings
ClinicalTrials.gov study NCT01412801. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
ClinicalTrials.gov study NCT02371265. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
ClinicalTrials.gov study NCT00000887. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
ClinicalTrials.gov study NCT00000920. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Does Provision of Point of Care CD4 Technology and Early Knowledge of CD4 Levels Affect Early Initiation and Retention on Anti-retroviral Treatment (ART) in HIV Positive Pregnant Women in the Context
ClinicalTrials.gov study NCT02070900. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
ClinicalTrials.gov study NCT02400021. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Factors Influencing the Utilization of Anti-Retroviral Drugs by HIV Positive Pregnant Women in Busia District, Busia County
<p>Antiretroviral drugs reduce viral replication in pregnant women either by lowering plasma viral load or through postexposure prophylaxis in their new born. Mother to child transmission is the predominant mode of transmission of HIV in infants and young children. This transmission occurs during pregnancy, labour and delivery and breastfeeding. Providing all HIV positive pregnant women with lifelong ARVs regardless of CD4 count/disease stage is an effective strategy to avert MTCT of HIV. Eliminating vertical transmissions globally is still a challenge. In Busia district, the uptake of antiretroviral drugs by HIV positive pregnant women is about 41%. Despite the varied interventions employed to avert MTCT a number of exposed babies have been seroconversion. Objective: Factors influencing utilization of ARVs by HIV positive pregnant women. Methods: Cross sectional study was done through Purposive and random sampling. The study area and the HIV positive pregnant women were purposively selected. Quantitative approach was employed using standardized questionnaires. Exploratory data analysis was preceded by monovariate analysis. Results were summarized using tables and text. The quantitative data was analyzed by Statistics package of social science. Results: Percentage (30.6%) of women started ARVs in the 3rd trimester. Percentage (37.4%) hides while taking the drugs due to self-stigma and fear of husband. Percentage 57.9% took freely. Half of those who were not on ARVs indicated they were afraid of their husbands while the other half were not willing to take the ARVs. Conclusion: We found out 85% of the women had their first antenatal care visit in the second trimester while (30.6%) started ARVs in the 3rd trimester. ARVs taken for more than 17 weeks reduces the risk of MTCT. Disclosure of HIV status of pregnant women is essential. Male participation in antenatal care, treatment, counselling and testing for HIV, will increase use of interventions for eMTCT.</p>
A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
ClinicalTrials.gov study NCT00000944. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
ClinicalTrials.gov study NCT00000878. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women
ClinicalTrials.gov study NCT03564613. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
ClinicalTrials.gov study NCT00000910. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
ClinicalTrials.gov study NCT00197366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation
ClinicalTrials.gov study NCT03777371. IPD Sharing: YES. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.